Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)
Benactyzine chemical structure | |
2-diethylaminoethyl 2-hydroxy-2,2-di(phenyl)acetate IUPAC name | |
CAS number 302-40-9 |
ATC code [[ATC_code_|]][1] |
PubChem 9330 |
DrugBank [2] |
Chemical formula | {{{chemical_formula}}} |
Molecular weight | 327.42 g/mol |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Pregnancy category | |
Legal status | |
Routes of administration |
Benactyzine is an anticholinergic drug. It is a glycolic acid ester, related to other drugs such as the piperidinyl benzilates and 3-Quinuclidinyl benzilate but with much less potent anticholinergic effects.
Benactyzine has been used as an antidepressant,[1] however its use for this application is limited by anticholinergic side effects such as dry mouth and nausea, and at high doses it can cause more severe symptoms such as deliriant and hallucinogenic effects. Consequently it is no longer widely used in medicine, although it is still a useful drug for scientific research.
See also[edit | edit source]
References[edit | edit source]
- ↑ McLaughlin B, Rickels K, Abidi M, Toro R. Meprobamate-benactyzine (Deprol) and placebo in two depressed outpatient populations. Psychosomatics. 1969 Mar-Apr;10(2):73-81.
Deliriants (anticholinergic hallucinogens) edit |
---|
{3-quinuclidinyl benzilate} {Atropine} {Dimenhydrinate} {Diphenhydramine} {Hyoscyamine} {Scopolamine} |
This page uses Creative Commons Licensed content from Wikipedia (view authors). |